Constantine Chinoporos, the Chief Operating Officer and Chief Business Officer of Applied Therapeutics, Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company with a market capitalization of ...
Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) by 13.6% during the 4th quarter, according to the company in its most ...
Jennison Associates LLC bought a new stake in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) in the 4th ...
15h
Zacks.com on MSNCRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...
Learn more about whether Bausch + Lomb Corporation or TransMedics Group, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether Bausch + Lomb Corporation or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
The United States market has been flat over the last week but is up 22% over the past year, with earnings expected to grow by 15% per annum in the coming years. In this context, identifying high ...
As global markets navigate a volatile start to 2025, with the Federal Reserve holding rates steady and AI competition shaking up the tech sector, investors are closely watching how these dynamics ...
SolarWinds Corporation ("SolarWinds" or the "Company"), a leading provider of simple, powerful, secure observability and IT management software, today announced that it has entered into a definitive ...
American Healthcare REIT, Inc. (the "Company") announced today that members of its board of directors and management team will ring The Opening Bell® at the New York Stock Exchange on Feb. 10, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results